{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T06:15:47Z","timestamp":1791008147620,"version":"4.1.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Neuroscience Research Group of the Hungarian Academy of Sciences and the University of Szeged"},{"DOI":"10.13039\/501100003549","name":"OTKA","doi-asserted-by":"crossref","award":["K75628"],"award-info":[{"award-number":["K75628"]}],"id":[{"id":"10.13039\/501100003549","id-type":"DOI","asserted-by":"crossref"}]},{"name":"T\u00c1MOP","award":["4.2.1\/B-09\/1\/KONV-2010-0005"],"award-info":[{"award-number":["4.2.1\/B-09\/1\/KONV-2010-0005"]}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.jns.2012.06.004","type":"journal-article","created":{"date-parts":[[2012,6,27]],"date-time":"2012-06-27T22:04:29Z","timestamp":1340834669000},"page":"187-191","source":"Crossref","is-referenced-by-count":81,"title":["Mitochondrial disturbances, excitotoxicity, neuroinflammation and kynurenines: Novel therapeutic strategies for neurodegenerative disorders"],"prefix":"10.1016","volume":"322","author":[{"given":"D\u00e9nes","family":"Z\u00e1dori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Kliv\u00e9nyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levente","family":"Szal\u00e1rdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferenc","family":"F\u00fcl\u00f6p","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f3zsef","family":"Toldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"V\u00e9csei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2012.06.004_bb0005","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1582-4934.2010.01237.x","article-title":"Endogenous neuroprotection in chronic neurodegenerative disorders: with particular regard to the kynurenines","volume":"15","author":"Zadori","year":"2011","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jns.2012.06.004_bb0010","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nm.2092","article-title":"Kynurenine is an endothelium-derived relaxing factor produced during inflammation","volume":"16","author":"Wang","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.jns.2012.06.004_bb0015","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/00004647-200101000-00002","article-title":"Reactive oxygen radicals in signaling and damage in the ischemic brain","volume":"21","author":"Chan","year":"2001","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.jns.2012.06.004_bb0020","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.bbadis.2009.09.002","article-title":"Mitochondrial and apoptotic neuronal death signaling pathways in cerebral ischemia","volume":"1802","author":"Niizuma","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jns.2012.06.004_bb0025","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrn1387","article-title":"Neurovascular regulation in the normal brain and in Alzheimer's disease","volume":"5","author":"Iadecola","year":"2004","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.jns.2012.06.004_bb0030","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1523\/JNEUROSCI.13-06-02651.1993","article-title":"Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures","volume":"13","author":"Dawson","year":"1993","journal-title":"J Neurosci"},{"key":"10.1016\/j.jns.2012.06.004_bb0035","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/ana.410240512","article-title":"Selective sparing of NADPH-diaphorase neurons in neonatal hypoxia-ischemia","volume":"24","author":"Ferriero","year":"1988","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2012.06.004_bb0040","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1161\/01.STR.24.12.2016","article-title":"Cerebral endothelial nitric oxide synthase expression after focal cerebral ischemia in rats","volume":"24","author":"Zhang","year":"1993","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2012.06.004_bb0045","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3181\/0902-MR-81","article-title":"Mitochondrial nitric oxide synthase: a masterpiece of metabolic adaptation, cell growth, transformation, and death","volume":"234","author":"Finocchietto","year":"2009","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.jns.2012.06.004_bb0050","doi-asserted-by":"crossref","first-page":"42447","DOI":"10.1074\/jbc.M204580200","article-title":"The modulation of mitochondrial nitric-oxide synthase activity in rat brain development","volume":"277","author":"Riobo","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jns.2012.06.004_bb0055","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.niox.2010.06.001","article-title":"Nitric oxide and neuronal death","volume":"23","author":"Brown","year":"2010","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.jns.2012.06.004_bb0060","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1113\/jphysiol.2011.210831","article-title":"Neurovascular protection by ischaemic tolerance: role of nitric oxide","volume":"589","author":"Iadecola","year":"2011","journal-title":"J Physiol"},{"key":"10.1016\/j.jns.2012.06.004_bb0065","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1523\/JNEUROSCI.0106-08.2008","article-title":"N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking","volume":"28","author":"Orr","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.jns.2012.06.004_bb0070","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nn884","article-title":"Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines","volume":"5","author":"Panov","year":"2002","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.jns.2012.06.004_bb0075","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00424-010-0809-1","article-title":"Glutamate receptors, neurotoxicity and neurodegeneration","volume":"460","author":"Lau","year":"2010","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.jns.2012.06.004_bb0080","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0006-8993(88)90765-2","article-title":"Glutamate becomes neurotoxic via the N-methyl-d-aspartate receptor when intracellular energy levels are reduced","volume":"451","author":"Novelli","year":"1988","journal-title":"Brain Res"},{"key":"10.1016\/j.jns.2012.06.004_bb0085","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1126\/science.284.5421.1845","article-title":"Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein","volume":"284","author":"Sattler","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.jns.2012.06.004_bb0090","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1523\/JNEUROSCI.0116-07.2007","article-title":"NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo","volume":"27","author":"Liu","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.jns.2012.06.004_bb0095","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0005-2728(98)00119-4","article-title":"From calcium signaling to cell death: two conformations for the mitochondrial permeability transition pore. Switching from low- to high-conductance state","volume":"1366","author":"Ichas","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jns.2012.06.004_bb0100","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF03033975","article-title":"Role of astrocytes in glutamate homeostasis: implications for excitotoxicity","volume":"8","author":"Schousboe","year":"2005","journal-title":"Neurotox Res"},{"key":"10.1016\/j.jns.2012.06.004_bb0105","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1152\/physrev.1999.79.4.1431","article-title":"Ischemic cell death in brain neurons","volume":"79","author":"Lipton","year":"1999","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jns.2012.06.004_bb0110","doi-asserted-by":"crossref","first-page":"5297","DOI":"10.1523\/JNEUROSCI.15-07-05297.1995","article-title":"NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum","volume":"15","author":"Landwehrmeyer","year":"1995","journal-title":"J Neurosci"},{"key":"10.1016\/j.jns.2012.06.004_bb0115","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2010.01.008","article-title":"Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington's disease mice","volume":"65","author":"Milnerwood","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.jns.2012.06.004_bb0120","doi-asserted-by":"crossref","first-page":"24713","DOI":"10.1074\/jbc.M103501200","article-title":"Polyglutamine-expanded huntingtin promotes sensitization of N-methyl-d-aspartate receptors via post-synaptic density 95","volume":"276","author":"Sun","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jns.2012.06.004_bb0125","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1046\/j.1471-4159.1999.0721890.x","article-title":"Subtype-specific enhancement of NMDA receptor currents by mutant huntingtin","volume":"72","author":"Chen","year":"1999","journal-title":"J Neurochem"},{"key":"10.1016\/j.jns.2012.06.004_bb0130","doi-asserted-by":"crossref","first-page":"33364","DOI":"10.1074\/jbc.M304240200","article-title":"Expression of polyglutamine-expanded huntingtin induces tyrosine phosphorylation of N-methyl-d-aspartate receptors","volume":"278","author":"Song","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jns.2012.06.004_bb0135","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0896-6273(03)00366-0","article-title":"Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1","volume":"39","author":"Tang","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.jns.2012.06.004_bb0140","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.1073\/pnas.95.11.6480","article-title":"Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene","volume":"95","author":"Cha","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jns.2012.06.004_bb0145","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s11064-007-9463-1","article-title":"Glutamate uptake is reduced in prefrontal cortex in Huntington's disease","volume":"33","author":"Hassel","year":"2008","journal-title":"Neurochem Res"},{"key":"10.1016\/j.jns.2012.06.004_bb0150","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/nm.2399","article-title":"The immunology of stroke: from mechanisms to translation","volume":"17","author":"Iadecola","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.jns.2012.06.004_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/CS20060043","article-title":"(Peri)vascular production and action of pro-inflammatory cytokines in brain pathology","volume":"112","author":"Konsman","year":"2007","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jns.2012.06.004_bb0160","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.tins.2007.07.007","article-title":"Neurotransmitter receptors on microglia","volume":"30","author":"Pocock","year":"2007","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.jns.2012.06.004_bb0165","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/jcbfm.1995.47","article-title":"Inducible nitric oxide synthase gene expression in brain following cerebral ischemia","volume":"15","author":"Iadecola","year":"1995","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.jns.2012.06.004_bb0170","first-page":"R286","article-title":"Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage","volume":"268","author":"Iadecola","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jns.2012.06.004_bb0175","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1212\/WNL.56.4.529","article-title":"Antibodies to brain antigens following stroke","volume":"56","author":"Bornstein","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2012.06.004_bb0180","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00702-010-0430-7","article-title":"Neuroinflammation in Huntington's disease","volume":"117","author":"Moller","year":"2010","journal-title":"J Neural Transm"},{"key":"10.1016\/j.jns.2012.06.004_bb0185","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jnen\/60.2.161","article-title":"Early and progressive accumulation of reactive microglia in the Huntington disease brain","volume":"60","author":"Sapp","year":"2001","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.jns.2012.06.004_bb0190","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/WNR.0b013e32832e34ee","article-title":"Distinct neuroinflammatory profile in post-mortem human Huntington's disease","volume":"20","author":"Silvestroni","year":"2009","journal-title":"Neuroreport"},{"key":"10.1016\/j.jns.2012.06.004_bb0195","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s11064-010-0187-2","article-title":"The role of tryptophan catabolism along the kynurenine pathway in acute ischemic stroke","volume":"35","author":"Brouns","year":"2010","journal-title":"Neurochem Res"},{"key":"10.1016\/j.jns.2012.06.004_bb0200","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1471-4159.2009.06442.x","article-title":"Blood levels of kynurenines, interleukin-23 and soluble human leucocyte antigen-G at different stages of Huntington's disease","volume":"112","author":"Forrest","year":"2010","journal-title":"J Neurochem"},{"key":"10.1016\/j.jns.2012.06.004_bb0205","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0006-8993(82)91048-4","article-title":"An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid","volume":"247","author":"Perkins","year":"1982","journal-title":"Brain Res"},{"key":"10.1016\/j.jns.2012.06.004_bb0210","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/j.1471-4159.1989.tb01881.x","article-title":"A glycine site associated with N-methyl-d-aspartic acid receptors: characterization and identification of a new class of antagonists","volume":"52","author":"Kessler","year":"1989","journal-title":"J Neurochem"},{"key":"10.1016\/j.jns.2012.06.004_bb0215","doi-asserted-by":"crossref","first-page":"7463","DOI":"10.1523\/JNEUROSCI.21-19-07463.2001","article-title":"The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications","volume":"21","author":"Hilmas","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.jns.2012.06.004_bb0220","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1046\/j.0022-3042.2002.00805.x","article-title":"Direct evidence that release-stimulating alpha7* nicotinic cholinergic receptors are localized on human and rat brain glutamatergic axon terminals","volume":"80","author":"Marchi","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.jns.2012.06.004_bb0225","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1471-4159.1998.70010299.x","article-title":"3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity","volume":"70","author":"Okuda","year":"1998","journal-title":"J Neurochem"},{"key":"10.1016\/j.jns.2012.06.004_bb0230","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0197-0186(95)00091-7","article-title":"The endogenous agonist quinolinic acid and the non endogenous homoquinolinic acid discriminate between NMDAR2 receptor subunits","volume":"28","author":"de Carvalho","year":"1996","journal-title":"Neurochem Int"},{"key":"10.1016\/j.jns.2012.06.004_bb0235","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0014-2999(81)90587-2","article-title":"Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS","volume":"72","author":"Stone","year":"1981","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jns.2012.06.004_bb0240","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1476-5381.1988.tb11474.x","article-title":"Quinolinic acid effects on amino acid release from the rat cerebral cortex in vitro and in vivo","volume":"93","author":"Connick","year":"1988","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jns.2012.06.004_bb0245","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0197-0186(01)00133-4","article-title":"Quinolinic acid stimulates synaptosomal glutamate release and inhibits glutamate uptake into astrocytes","volume":"40","author":"Tavares","year":"2002","journal-title":"Neurochem Int"},{"key":"10.1016\/j.jns.2012.06.004_bb0250","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/BF00966592","article-title":"Quinolinic acid is a potent lipid peroxidant in rat brain homogenates","volume":"16","author":"Rios","year":"1991","journal-title":"Neurochem Res"},{"key":"10.1016\/j.jns.2012.06.004_bb0255","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1038\/sj.bjp.0702940","article-title":"Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: protection by melatonin and deprenyl","volume":"128","author":"Behan","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jns.2012.06.004_bb0260","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00702-011-0676-8","article-title":"Involvement of kynurenines in Huntington's disease and stroke-induced brain damage","volume":"119","author":"Stone","year":"2012","journal-title":"J Neural Transm."},{"key":"10.1016\/j.jns.2012.06.004_bb0265","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/jcbfm.1992.57","article-title":"Neuroprotective effects of L-kynurenine on hypoxia-ischemia and NMDA lesions in neonatal rats","volume":"12","author":"Nozaki","year":"1992","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.jns.2012.06.004_bb0270","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00005344-200309000-00012","article-title":"Effect of systemic administration of L-kynurenine on corticocerebral blood flow under normal and ischemic conditions of the brain in conscious rabbits","volume":"42","author":"Sas","year":"2003","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jns.2012.06.004_bb0275","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejphar.2007.02.029","article-title":"Neuroprotective effect of L-kynurenine sulfate administered before focal cerebral ischemia in mice and global cerebral ischemia in gerbils","volume":"564","author":"Gigler","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jns.2012.06.004_bb0280","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.nbd.2008.07.013","article-title":"Kynurenine diminishes the ischemia-induced histological and electrophysiological deficits in the rat hippocampus","volume":"32","author":"Sas","year":"2008","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.jns.2012.06.004_bb0285","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.lfs.2008.02.014","article-title":"Neuroprotection achieved in the ischaemic rat cortex with L-kynurenine sulphate","volume":"82","author":"Robotka","year":"2008","journal-title":"Life Sci"},{"key":"10.1016\/j.jns.2012.06.004_bb0290","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0304-3940(92)90186-B","article-title":"The effect of peripheral loading with kynurenine and probenecid on extracellular striatal kynurenic acid concentrations","volume":"146","author":"Miller","year":"1992","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jns.2012.06.004_bb0295","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00702-009-0253-6","article-title":"Neuroprotective effects of probenecid in a transgenic animal model of Huntington's disease","volume":"116","author":"Vamos","year":"2009","journal-title":"J Neural Transm"},{"key":"10.1016\/j.jns.2012.06.004_bb0300","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/sj.bjp.0701834","article-title":"Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid","volume":"124","author":"Harris","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jns.2012.06.004_bb0305","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/978-1-4615-4709-9_26","article-title":"Neuroprotective effects of kynurenine-3-hydroxylase inhibitors in models of brain ischemia","volume":"467","author":"Moroni","year":"1999","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jns.2012.06.004_bb0310","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/978-1-4615-0135-0_15","article-title":"Studies on the neuroprotective action of kynurenine mono-oxygenase inhibitors in post-ischemic brain damage","volume":"527","author":"Moroni","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jns.2012.06.004_bb0315","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/00004647-199907000-00007","article-title":"Kynurenine hydroxylase inhibitors reduce ischemic brain damage: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[\u2212N-4-(nitrophenyl)thiazol-2yl]-benzenesulfonamide (Ro 61\u20138048) in models of focal or global brain ischemia","volume":"19","author":"Cozzi","year":"1999","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.jns.2012.06.004_bb0320","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/ng1542","article-title":"A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease","volume":"37","author":"Giorgini","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.jns.2012.06.004_bb0325","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.cell.2011.05.020","article-title":"Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration","volume":"145","author":"Zwilling","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jns.2012.06.004_bb0330","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0165-6147(00)01451-6","article-title":"Development and therapeutic potential of kynurenic acid and kynurenine derivatives for neuroprotection","volume":"21","author":"Stone","year":"2000","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jns.2012.06.004_bb0335","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.coph.2003.10.006","article-title":"The kynurenine pathway of tryptophan degradation as a drug target","volume":"4","author":"Schwarcz","year":"2004","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.jns.2012.06.004_bb0340","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.2174\/092986709789909602","article-title":"Syntheses, transformations and pharmaceutical applications of kynurenic acid derivatives","volume":"16","author":"Fulop","year":"2009","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.jns.2012.06.004_bb0345","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1006\/exnr.1999.7284","article-title":"In situ produced 7-chlorokynurenate provides protection against quinolinate- and malonate-induced neurotoxicity in the rat striatum","volume":"163","author":"Guidetti","year":"2000","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jns.2012.06.004_bb0350","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0003-9861(80)90164-2","article-title":"Metabolism of 6-chlorotryptophan to 4-chloro-3-hydroxyanthranilic acid: a potent inhibitor of 3-hydroxyanthranilic acid oxidase","volume":"203","author":"Parli","year":"1980","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.jns.2012.06.004_bb0355","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejphar.2011.05.069","article-title":"Neuroprotection with a new kynurenic acid analog in the four-vessel occlusion model of ischemia","volume":"667","author":"Gellert","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jns.2012.06.004_bb0360","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00702-010-0573-6","article-title":"Neuroprotective effects of a novel kynurenic acid analogue in a transgenic mouse model of Huntington's disease","volume":"118","author":"Zadori","year":"2011","journal-title":"J Neural Transm"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X12002870?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X12002870?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T04:07:19Z","timestamp":1588824439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X12002870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":72,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0022510X12002870"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2012.06.004","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}